• 1
    Pihlajaniemi T, Rehn M 1995 Two new collagen subgroups: Membrane associated collagens and types XV and XVIII. Prog Nucleic Acid Res Mol Biol 50: 225262.
  • 2
    Hashimoto T, Wakabayashi T, Watanabe A, Kowa H, Hosoda R, Nakamura A, Kanazawa I, Arai T, Takio K, Mann DM, Iwatsubo T 2002 CLAC: A novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV. EMBO J 21: 15241534.
  • 3
    Banyard J, Bao L, Zetter BR 2003 Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells. J Biol Chem 278: 2098920994.
  • 4
    Sandberg M, Tamminen M, Hirvonen H, Vuorio E, Pihlajaniemi T 1989 Expression of mRNAs coding for the α1 chain of type XIII collagen in human fetal tissues: comparison with expression of mRNAs for collagen types I, II, and III. J Cell Biol 109: 13711379.
  • 5
    Sund M, Väisänen T, Kaukinen S, Ilves M, Tu H, Autio-Harmainen H, Rauvala H, Pihlajaniemi T 2001 Distinct expression of type XIII collagen in neuronal structures and other tissues during mouse development. Matrix Biol 20: 215231.
  • 6
    Peltonen S, Hentula M, Hägg P, Ylä-Outinen H, Tuukkanen J, Lakkakorpi J, Rehn M, Pihlajaniemi T, Peltonen J 1999 A novel component of epidermal cell-matrix and cell-cell contacts: transmembrane protein type XIII collagen. J Invest Dermatol 113: 635642.
  • 7
    Hägg P, Väisänen T, Tuomisto A, Rehn M, Tu H, Huhtala P, Eskelinen S, Pihlajaniemi T 2001 Type XIII collagen: a novel cell adhesion component present in a range of cell-matrix adhesions and in the intercalated discs between cardiac muscle cells. Matrix Biol 19: 727742.
  • 8
    Nykvist P, Tu H, Ivaska J, Käpylä J, Pihlajaniemi T, Heino J 2000 Distinct recognition of collagen subtypes by alpha(1)beta(1) and alpha(2)beta(1) integrins. Alpha(1)beta(1) mediates cell adhesion to type XIII collagen. J Biol Chem 275: 82558261.
  • 9
    Snellman A, Tu H, Väisänen T, Kvist AP, Huhtala P, Pihlajaniemi T 2000 A short sequence in the N-terminal region is required for the trimerization of type XIII collagen and is conserved in other collagenous transmembrane proteins. EMBO J 19: 50515059.
  • 10
    Tu H, Sasaki T, Snellman A, Gohring W, Pirilä P, Timpl R, Pihlajaniemi T 2002 The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin. J Biol Chem 277: 2309223099.
  • 11
    Snellman A, Keränen MR, Hägg PO, Lamberg A, Hiltunen JK, Kivirikko KI, Pihlajaniemi T 2000 Type XIII collagen forms homotrimers with three triple helical collagenous domains and its association into disulfide-bonded trimers is enhanced by prolyl 4-hydroxylase. J Biol Chem 275: 89368944.
  • 12
    Juvonen M, Pihlajaniemi T 1992 Characterization of the spectrum of alternative splicing of α1(XIII) collagen transcripts in HT-1080 cells and calvarial tissue resulted in identification of two previously unidentified alternatively spliced sequences, one previously unidentified exon, and nine new mRNA variants. J Biol Chem 267: 2469324699.
  • 13
    Juvonen M, Sandberg M, Pihlajaniemi T 1992 Patterns of expression of the six alternatively spliced exons affecting the structures of the COL1 and NC2 domains of the α1(XIII) collagen chain in human tissues and cell lines. J Biol Chem 267: 2470024707.
  • 14
    Juvonen M, Pihlajaniemi T, Autio-Harmainen H 1993 Location and alternative splicing of type XIII collagen RNA in the early human placenta. Lab Invest 69: 541551.
  • 15
    Peltonen S, Rehn M, Pihlajaniemi T 1997 Alternative splicing of mouse α1(XIII) collagen RNAs results in at least 17 different transcripts, predicting α1(XIII) collagen chains with length varying between 651 and 710 amino acid residues. DNA Cell Biol 16: 227234.
  • 16
    Kvist AP, Latvanlehto A, Sund M, Eklund L, Väisänen T, Hägg P, Sormunen R, Komulainen J, Fässler R, Pihlajaniemi T 2001 Lack of cytosolic and transmembrane domains of type XIII collagen results in progressive myopathy. Am J Pathol 159: 15811592.
  • 17
    Sund M, Ylönen R, Tuomisto A, Sormunen R, Tahkola J, Kvist AP, Kontusaari S, Autio-Harmainen H, Pihlajaniemi T 2001 Abnormal adherence junctions in the heart and reduced angiogenesis in transgenic mice overexpressing mutant type XIII collagen. EMBO J 20: 51535164.
  • 18
    Hägg P, Rehn M, Huhtala P, Väisänen T, Tamminen M, Pihlajaniemi T 1998 Type XIII collagen is identified as a plasma membrane protein. J Biol Chem 273: 1559015597.
  • 19
    Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Biochem 162: 156159.
  • 20
    McLeod MJ 1980 Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22: 299301.
  • 21
    Selby PB 1987 A rapid method for preparing high quality alizarin stained skeletons of adult mice. Stain Technol 62: 143146.
  • 22
    Jämsä T, Jalovaara P, Peng Z, Väänänen HK, Tuukkanen J 1998 Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia. Bone 23: 155161.
  • 23
    Lakkakorpi P, Tuukkanen J, Hentunen T, Järvelin K, Väänänen K 1989 Organization of osteoclasts microfilaments during the attachment to bone surface in vitro. J Bone Miner Res 4: 817825.
  • 24
    Selander K, Lehenkari P, Väänänen HK 1994 The effects of biphosphonates on the resorption cycle of isolated osteoclasts. Calcif Tissue Int 37: 646650.
  • 25
    Myllyharju J, Kivirikko KI 2001 Collagens and collagen-related diseases. Ann Med 33: 721.
  • 26
    Prockop DJ, Kivirikko KI 1995 Collagens: Molecular biology, diseases, and potentials for therapy. Annu Rev Biochem 64: 403434.
  • 27
    Kvist AP, Latvanlehto A, Sund M, Horelli-Kuitunen N, Rehn M, Palotie A, Beier D, Pihlajaniemi T 1999 Complete exon-intron organization and chromosomal location of the gene for mouse type XIII collagen (col13a1) and comparison with its human homologue. Matrix Biol 18: 261274.
  • 28
    Karsenty G 1999 The genetic transformation of bone biology. Genes Dev 13: 30373051.
  • 29
    Mundlos S, Olsen BR 1997 Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J 11: 125132.
  • 30
    Mundlos S, Olsen BR 1997 Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development-matrix components and their homeostasis. FASEB J 11: 227233.
  • 31
    Chambers TJ 2000 Regulation of the differentation and function of osteoclasts. J Pathol 192: 413.
  • 32
    Jochum W, David JP, Elliott C, Wutz A, Plenk H Jr, Matsuo K, Wagner EF 2000 Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 6: 980984.
  • 33
    Sabatakos G, Sims NA, Chen J, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Ford K, Nestler EJ, Baron R 2000 Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 6: 985990.
  • 34
    Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G 1996 Increased bone formation in osteocalcin-deficient mice. Nature 382: 448452.
  • 35
    Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100: 197207.
  • 36
    Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R 1995 Toward a molecular understanding of skeletal development. Cell 80: 371378.
  • 37
    Weinreb M, Rodan GA, Thompson DD 1989 Osteopenia in the immobilized rat hind limb is associated with increased bone resorption and decreased bone formation. Bone 10: 187194.
  • 38
    Hillam RA, Skerry TM 1995 Inhibition of bone resorption and stimulation of formation by mechanical loading of the modeling rat ulna in vivo. J Bone Miner Res 10: 683689.
  • 39
    Jämsä T, Tuukkanen J, Jalovaara P 1998 Femoral neck strength of mouse in two loading configurations: Method evaluation and fracture characteristics. J Biomech 31: 723729.
  • 40
    Mullender MG, Huiskes R 1997 Osteocytes and bone lining cells: Which are the best candidates for mechano-sensors in cancellous bone? Bone 20: 527532.
  • 41
    Chow JW, Fox SW, Lean JM, Chambers TJ 1998 Role of nitric oxide and prostaglandins in mechanically induced bone formation. J Bone Miner Res 13: 10391044.
  • 42
    Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755764.
  • 43
    Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ 1997 Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765771.
  • 44
    Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747754.
  • 45
    Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G 1999 A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13: 10251036.
  • 46
    Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, Komori T, Nagatsuka M 1999 Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274: 69726978.
  • 47
    Jimenez MJ, Balbin M, Lopez JM, Alvarez J, Komori T, Lopez-Otin C 1999 Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19: 44314442.
  • 48
    Strong DD, Beachler AL, Wergedal JE, Linkhart TA 1991 Insulinlike growth factor II and transforming growth factor beta regulate collagen expression in human osteoblast-like cells in vitro. J Bone Miner Res 6: 1523.
  • 49
    Ishibe M, Ishibashi T, Kaneda K, Koda T, Rosier RN, Puzas JE 1998 Stimulation of bone formation in vivo by insulin-like growth factor-II in rats. Calcif Tissue Int 63: 3638.